GlaxoSmithKline (GSK)

1,749.50p
   
  • Change Today:
      7.50p
  • 52 Week High: 1,773.00
  • 52 Week Low: 1,317.50
  • Currency: UK Pounds
  • Shares Issued: 4,927.46m
  • Volume: 4,614,446
  • Market Cap: £86,206m
  • RiskGrade: 81
  • Beta: 0.58

Dividends

Year End Type Amount Payment Date Ex-Div Date Record Date
31-Dec-08 Q1 13.00p 10-Jul-08 30-Apr-08 02-May-08
  Q2 13.00p 09-Oct-08 30-Jul-08 01-Aug-08
  Q3 14.00p 08-Jan-09 29-Oct-08 31-Oct-08
  Q4 17.00p 09-Apr-09 11-Feb-09 13-Feb-09
31-Dec-08 1st Interim 11.00p 06-Jul-06 10-May-06 12-May-06
  2nd Interim 11.00p 05-Oct-06 02-Aug-06 04-Aug-06
  3rd Interim 12.00p 04-Jan-07 01-Nov-06 03-Nov-06
  4th Interim 14.00p 12-Apr-07 14-Feb-07 16-Feb-07
31-Dec-09 Q1 14.00p 09-Jul-09 29-Apr-09 01-May-09
  Q2 14.00p 08-Oct-09 29-Jul-09 31-Jul-09
  Q3 15.00p 07-Jan-10 04-Nov-09 06-Nov-09
  Q4 18.00p 08-Apr-10 10-Feb-10 12-Feb-10
31-Dec-10 Q1 15.00p 08-Jul-10 05-May-10 07-May-10
  Q2 15.00p 07-Oct-10 28-Jul-10 30-Jul-10
  Q3 16.00p 06-Jan-11 27-Oct-10 29-Oct-10
  Q4 19.00p 07-Apr-11 09-Feb-11 11-Feb-11
31-Dec-11 Q1 16.00p 07-Jul-11 04-May-11 06-May-11
  Q2 16.00p 06-Oct-11 03-Aug-11 05-Aug-11
  Q3 17.00p 05-Jan-12 02-Nov-11 04-Nov-11
  Q4 21.00p 12-Apr-12 15-Feb-12 17-Feb-12
  Special 5.00p 12-Apr-12 15-Feb-12 17-Feb-12
31-Dec-12 Q1 17.00p 05-Jul-12 09-May-12 11-May-12
  Q2 17.00p 04-Oct-12 08-Aug-12 10-Aug-12
  Q3 18.00p 03-Jan-13 14-Nov-12 16-Nov-12
  Q4 22.00p 11-Apr-13 20-Feb-13 22-Feb-13
31-Dec-13 Q1 18.00p 11-Jul-13 08-May-13 10-May-13

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Historical interim dividends and record dates not previously collected

Note 4: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,749.50p
Change Today 7.50p
% Change 0.43 %
52 Week High 1,773.00
52 Week Low 1,317.50
Volume 4,614,446
Shares Issued 4,927.46m
Market Cap £86,206m
Beta 0.58
RiskGrade 81

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.33% below the market average66.33% below the market average66.33% below the market average66.33% below the market average66.33% below the market average
8.70% above the sector average8.70% above the sector average8.70% above the sector average8.70% above the sector average8.70% above the sector average
Price Trend
61.19% above the market average61.19% above the market average61.19% above the market average61.19% above the market average61.19% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Income
72.21% above the market average72.21% above the market average72.21% above the market average72.21% above the market average72.21% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Growth
16.49% below the market average16.49% below the market average16.49% below the market average16.49% below the market average16.49% below the market average
38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average

What The Brokers Say

Strong Buy 9
Buy 1
Neutral 14
Sell 2
Strong Sell 4
Total 30
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q1 Q4
Ex-Div 08-May-13 20-Feb-13
Paid 11-Jul-13 11-Apr-13
Amount 18.00p 22.00p

Trades for 24-May-2013

Time Volume / Share Price
16:41 25,517 @ 1,749.50p
16:41 17,996 @ 1,738.07p
16:41 19,567 @ 1,736.24p
16:37 6,665 @ 1,731.88p
16:35 1,423,426 @ 1,749.50p

GlaxoSmithKline Key Personnel

CEO Sir Andrew P Witty

Top of Page